未登录

T

Tanveer Singh

university of illinois at urbana-champaign

H指数:19

被引数:1,184

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

APOE4 reduces hippocampal expression of phosphoglycerate kinase 1 and sodium potassium pump to enhance seizure susceptibility in mice

APOE4降低小鼠海马区磷酸甘油酸激酶1和钠钾泵的表达以增强其癫痫易感性。

Neurobiology of Disease

IF5.6

2025-12-240

OAAI

Neurosteroid mitigation of developmental neurological dysfunction, long-term epileptic biomarkers, chronic neuroinflammation, and neurodegeneration in a pediatric rat model of organophosphate exposure

神经甾体对有机磷暴露的儿科大鼠模型中发育性神经功能异常、长期癫痫生物标志物、慢性神经炎症和神经退行性变的缓解作用

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

IF3.8

2025-05-010

OAAI

Quality Improvement Essentials and Teaching Quality Improvement

质量改进基础与教学质量改进

Medical Clinics of North America

IF4.2

2025-04-300

PRE

Ehretia laevis mitigates paracetamol- induced hepatotoxicity by attenuating oxidative stress and inflammation in rats

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2024-12-010

PRE

3-hydroxy-3′,4′,5′-trimethoxyflavone protects rats against lead-induced neurotoxicity via chelation and modulating oxidative stress, inflammatory and monoaminergic systems

JOURNAL OF FUNCTIONAL FOODS

IF4

2024-07-012

OAAI

A Pediatric Rat Model of Organophosphate-Induced Refractory Status Epilepticus: Characterization of Long-Term Epileptic Seizure Activity, Neurologic Dysfunction and Neurodegeneration

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

IF3.8

2024-02-018

OAAI

Protective Activity of Novel Hydrophilic Synthetic Neurosteroids on Organophosphate Status Epilepticus-induced Chronic Epileptic Seizures, Non-Convulsive Discharges, High-Frequency Oscillations, and Electrographic Ictal Biomarkers

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

IF3.8

2024-02-014

OAAI

Neuroprotectant Activity of Novel Water-Soluble Synthetic Neurosteroids on Organophosphate Intoxication and Status Epilepticus-Induced Long-Term Neurological Dysfunction, Neurodegeneration, and Neuroinflammation

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

IF3.8

2024-02-0118

OAAI

Sex Differences in Organophosphate Model of Benzodiazepine-Refractory Status Epilepticus and Neuronal Damage

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

IF3.8

2024-02-018

OAAI

In Silico Approaches to Developing Novel Glycogen Synthase Kinase 3β (GSK-3β)

IF3.9

2023-10-131

OAAI

Computational Studies to Understand the Neuroprotective Mechanism of Action Basil Compounds

IF4.6

2023-10-105

OAAI

Clinical Significance of Adropin and Afamin in Evaluating Renal Function and Cardiovascular Health in the Presence of CKD-MBD Biomarkers in Chronic Kidney Disease

IF3.3

2023-10-094

OAAI

Recent Development of Novel Aminoethyl-Substituted Chalcones as Potential Drug Candidates for the Treatment of Alzheimer's Disease

IF4.6

2023-09-125

OAAI

Scaffold Morphing and In Silico Design of Potential BACE-1 ( β-Secretase) Inhibitors: A Hope for a Newer Dawn in Anti-Alzheimer Therapeutics

IF4.6

2023-08-127

OAAI

Anticonvulsant potential of Grewia tiliaefolia in pentylenetetrazole induced epilepsy: insights from in vivo and in silico studies

METABOLIC BRAIN DISEASE

IF3.5

2023-07-124

OA

Promising biomarkers and therapeutic targets for the management of Parkinson's disease: recent advancements and contemporary research

METABOLIC BRAIN DISEASE

IF3.5

2023-02-205

PRE

Recent Developments in Diagnosis of Epilepsy: Scope of MicroRNA and Technological Advancements

IF3.5

2021-10-2522

OAAI

Anticonvulsant Effect of Asparagus racemosus Willd. in a Mouse Model of Catamenial Epilepsy

NEUROCHEMICAL RESEARCH

IF3.8

2021-10-088

PREAI

Epilepsy Associated Depression: An Update on Current Scenario, Suggested Mechanisms, and Opportunities

癫痫相关的抑郁症: 当前情况，建议的机制和机会的更新

NEUROCHEMICAL RESEARCH

IF3.8

2021-03-0435

PREAI

Neocortical injury-induced status epilepticus

IF6.6

2020-10-1628

OAAI